# BerryVin (Vitis vinifera and Vaccinium angustifolium)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/berryvin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Vitis vinifera and Vaccinium angustifolium blend, Grape and lowbush blueberry extract, Grape-blueberry antioxidant complex, Vitis-Vaccinium extract blend, Lowbush blueberry-grape combination, V. vinifera-V. angustifolium extract

## Overview

BerryVin is a proprietary blend combining Vitis vinifera (grape) and Vaccinium angustifolium (wild blueberry) extracts, delivering polyphenols including resveratrol, oligomeric proanthocyanidins (OPCs), and anthocyanins. These bioactives act as [free radical scaveng](/ingredients/condition/antioxidant)ers and upregulate endogenous antioxidant enzymes, theoretically supporting vascular and cellular protection.

## Health Benefits

• No direct clinical evidence exists for BerryVin specifically - benefits are theoretical based on component ingredients
• Related Vaccinium species (cranberry) show UTI prevention in women with recurrent infections (RR 0.68, moderate evidence from Cochrane review)
• Cranberry extracts demonstrate 49-59% reduction in antibiotic use for UTIs (moderate-low certainty evidence from network meta-analysis)
• Anti-adhesion effects against E. coli through A-type proanthocyanidins (mechanism studies only)
• Potential [antioxidant activity](/ingredients/condition/antioxidant) from polyphenols (no clinical trials for BerryVin)

## Mechanism of Action

Anthocyanins from Vaccinium angustifolium and OPCs from Vitis vinifera neutralize [reactive oxygen species](/ingredients/condition/antioxidant) (ROS) by donating hydrogen atoms, while resveratrol activates SIRT1 deacetylase and upregulates Nrf2-mediated transcription of antioxidant enzymes including superoxide dismutase (SOD) and catalase. Proanthocyanidins also inhibit NF-κB signaling, reducing downstream expression of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as TNF-α and IL-6. Additionally, grape-derived OPCs inhibit xanthine oxidase, directly reducing superoxide anion production at the enzymatic level.

## Clinical Summary

No randomized controlled trials exist specifically for the BerryVin blend, making direct efficacy claims unsupported by clinical evidence. Component-level data provides context: a Cochrane meta-analysis of cranberry (a related Vaccinium species) found a relative risk reduction of 0.68 for recurrent UTIs in women across trials involving hundreds of participants. Vitis vinifera grape seed extract has been studied in small RCTs (n=20–80) showing reductions in [oxidative stress](/ingredients/condition/antioxidant) biomarkers such as malondialdehyde (MDA) and improvements in flow-mediated dilation at doses of 150–300 mg daily. Extrapolation from these component studies to BerryVin requires caution, as synergistic or antagonistic interactions between the two extracts have not been formally evaluated.

## Nutritional Profile

BerryVin is a proprietary blend combining Vitis vinifera (grape) and Vaccinium angustifolium (lowbush blueberry) extracts; exact standardization ratios are not publicly disclosed, limiting precise concentration data. Based on known constituent profiles: Polyphenols are the dominant bioactive class — Vitis vinifera components contribute oligomeric proanthocyanidins (OPCs) typically at 80-95% purity in standardized grape seed extracts, resveratrol (trans-resveratrol ~50-100 mcg/g in skin extracts), quercetin, kaempferol, and anthocyanins (primarily in grape skin, ~1.5-3 mg cyanidin-3-glucoside equivalents per gram). Vaccinium angustifolium contributes anthocyanins at higher concentrations than highbush blueberry (~3.9-4.5 mg/g fresh weight basis, primarily delphinidin, cyanidin, petunidin, peonidin, and malvidin glycosides), pterostilbene (~0.03-0.1 mg/g, higher bioavailability than resveratrol due to methyl groups increasing lipophilicity), chlorogenic acid (~1-3 mg/g), and hydroxycinnamic acids. Macronutrient contribution is negligible at standard supplemental doses (typically 100-500 mg extract/day). Micronutrients include trace manganese (~0.1-0.3 mg per serving equivalent), vitamin C (~2-5 mg per serving from berry fraction, largely process-dependent), and vitamin K (trace, <5 mcg). Fiber content is minimal in extract form versus whole fruit. Bioavailability notes: anthocyanins show limited oral bioavailability (~1-2% absorption), metabolized extensively by colonic microbiota into phenolic acids (protocatechuic acid, vanillic acid) which may account for systemic effects; OPC bioavailability is molecular-weight dependent with monomers and dimers absorbed intact while larger polymers require microbial degradation; pterostilbene bioavailability (~80%) substantially exceeds resveratrol (~20-30%) due to enhanced lipid solubility and reduced first-pass [metabolism](/ingredients/condition/weight-management).

## Dosage & Preparation

No clinically studied dosages exist for BerryVin. Comparable cranberry extracts in trials used 400 mg capsules daily, with PAC standardization typically at 36 mg/day. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

BerryVin is generally considered well-tolerated at typical supplemental doses, with the most commonly reported adverse effects being mild gastrointestinal upset, including nausea and loose stools, particularly on an empty stomach. Grape-derived resveratrol and OPCs possess antiplatelet activity and may potentiate the effects of anticoagulants such as warfarin and antiplatelet drugs like clopidogrel, increasing bleeding risk. Vaccinium-derived anthocyanins may modestly affect CYP3A4 and CYP2C9 enzyme activity, potentially altering plasma levels of drugs metabolized by these pathways. Pregnant and breastfeeding individuals should avoid this blend due to insufficient safety data, and individuals scheduled for surgery should discontinue use at least two weeks prior.

## Scientific Research

No clinical trials, RCTs, or meta-analyses specifically on BerryVin were identified in the research. Related evidence comes from cranberry studies including a Cochrane review of 50 RCTs (n=8857) and a network meta-analysis of 20 RCTs (n=3091), but these investigated different Vaccinium species for UTI prevention, not the BerryVin blend.

## Historical & Cultural Context

No historical or traditional use data exists for BerryVin as a branded blend. While cranberries (related Vaccinium species) are widely used today, the research indicates their UTI applications lack strong traditional roots and represent primarily modern usage post-2000.

## Synergistic Combinations

Vitamin C, quercetin, resveratrol, green tea extract, alpha-lipoic acid

## Frequently Asked Questions

### What is BerryVin and what does it contain?

BerryVin is a proprietary polyphenol blend combining Vitis vinifera (grape) extract and Vaccinium angustifolium (wild blueberry) extract. Its key bioactives include resveratrol, oligomeric proanthocyanidins (OPCs), and anthocyanins such as cyanidin-3-glucoside, all of which contribute to its antioxidant profile. Because it is a proprietary formulation, the exact standardized ratio of each extract may vary by manufacturer.

### Is there clinical evidence that BerryVin works?

Currently, no clinical trials have been conducted on BerryVin as a combined formula, so its efficacy in humans is theoretical and extrapolated from component research. Studies on isolated grape seed OPCs and Vaccinium species extracts individually show promising antioxidant and vascular effects, but synergistic benefits of the specific blend remain unproven. Consumers should treat efficacy claims with appropriate skepticism until dedicated RCTs are published.

### What is the recommended dosage for BerryVin?

No established clinical dosage exists for BerryVin specifically due to the absence of dedicated human trials. Based on component research, grape seed extract is typically studied at 150–300 mg per day and wild blueberry extract at 500–1000 mg per day standardized to 25% anthocyanins. Always follow the manufacturer's label dosing and consult a healthcare provider, as optimal dosing for the combined formula has not been determined.

### Can BerryVin interact with blood thinners or medications?

Yes, BerryVin carries a meaningful interaction risk with anticoagulant and antiplatelet medications. Both grape-derived OPCs and resveratrol inhibit platelet aggregation and may amplify the effects of warfarin (increasing INR) or drugs like aspirin and clopidogrel, raising bleeding risk. Additionally, anthocyanins from blueberry may inhibit CYP3A4 and CYP2C9 liver enzymes, potentially elevating blood levels of statins, certain benzodiazepines, and other co-administered drugs.

### How does BerryVin compare to taking grape seed extract or blueberry extract alone?

Grape seed extract and wild blueberry extract each have independent research bases, with grape seed OPCs showing cardiovascular and oxidative stress benefits in small RCTs at 150–300 mg daily, and blueberry anthocyanins demonstrating cognitive and vascular benefits in trials at 500–1000 mg daily. BerryVin theoretically combines these mechanisms—OPC-mediated xanthine oxidase inhibition alongside Nrf2 activation from anthocyanins—but whether this combination produces additive, synergistic, or redundant effects is unknown. Until head-to-head studies exist, the comparative advantage of BerryVin over single-ingredient extracts cannot be substantiated.

### Does BerryVin have any evidence for urinary tract health, given its blueberry content?

While BerryVin itself lacks direct clinical studies, its Vaccinium angustifolium (wild blueberry) component is related to cranberry species that show moderate evidence for reducing recurrent UTI risk in women, with some studies demonstrating 49-59% reductions in antibiotic use. However, the specific efficacy of wild blueberry versus cranberry for UTI prevention remains understudied, so claims should be viewed as theoretical rather than proven for BerryVin specifically. Anyone with recurrent UTIs should discuss supplementation with their healthcare provider.

### What makes BerryVin different from just taking standalone grape seed extract and blueberry supplements?

BerryVin is a branded combination that standardizes both Vitis vinifera (grape seed) and Vaccinium angustifolium (wild blueberry) in a single formula, potentially offering convenience and consistent polyphenol ratios. However, no clinical research directly compares BerryVin's fixed combination to individual extracts taken separately, so it is unclear whether the combination provides synergistic benefits beyond what each ingredient offers alone. The choice between a combination product and standalone extracts often depends on personal preference, cost, and whether specific dosing of each component is desired.

### Who would be the best candidate to use BerryVin as a supplement?

BerryVin may be most relevant for individuals seeking antioxidant support from polyphenol-rich sources, though evidence is largely theoretical rather than proven through human trials specific to this branded ingredient. Women with recurrent urinary tract infections might consider it as a complementary option given the moderate evidence for related Vaccinium species, though cranberry-specific supplements have stronger research support. Anyone interested in BerryVin should consult a healthcare provider, particularly if they take blood-thinning medications or have existing health conditions, to ensure appropriateness.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*